Abstract
Objective To study the inhibitory effect of docetaxel (DOC), oxaliplatin (OXA) and their combination on proliferation of cervical cancer line HeLa. Methods Cell morphological changes were observed by inverted phase contrast microscope, cell inhibition rates in different groups were examined by MTT, and cell cycle and apoptosis rates were determined by flow cytometry (FCM). Results DOC and OXA inhibited the proliferation of cervical cancer cell line HeLa in a dose-dependent, and combination of the two drugs had an enhanced inhibitory effect; the apoptosis rate was also significantly increased when the two drugs were used in combination. Conclusion DOC and OXA can synergistically inhibit the proliferation of cervical cancer cell line HeLa, which indicates that combination of the two drugs might has a promising future for clinical treatment of cervical cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
